Robert Steinbach

Has grant

Friedrich Schiller University Jena

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Open

Developing an individually and globally applicable mri biomarker of Amyotrophic Lateral Sclerosis (ALS) disease progression: a multimodal approach

Open Date: 2024-04-01

Close Date: 2027-03-01

Grant: Close

Developing a mri surrogate parameter for disease progression in amyotrophic lateral sclerosis

Open Date: 2019-11-01

Close Date: 2022-08-01

Grant: Close

scholarship for studies

Open Date: 2012-01-01

Close Date: 2015-01-01

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Collaborators (2)

Christoph Neuwirth

Deputy Head

Kantonsspital St. Gallen

SWITZERLAND

View details

André Maier

Charité Universitätsmedizin Berlin - Campus Virchow-Klinikum

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Robert Steinbach

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Motor phenotypes of amyotrophic lateral sclerosis - a three-determinant anatomical classification based on the region of onset, propagation of motor symptoms, and the degree of upper and lower motor neuron dysfunction.

Provision, cough efficacy and treatment satisfaction of mechanical insufflation-exsufflation in a large multicenter cohort of patients with amyotrophic lateral sclerosis.

Self-assessment of amyotrophic lateral sclerosis functional rating scale on the patient's smartphone proves to be non-inferior to clinic data capture.

Response to Fortin-Bédard et al. “User expectations and experiences of an assistive robotic arm in amyotrophic lateral sclerosis: a multicenter observational study”

Dextromethorphan/quinidine (DMQ) for reducing bulbar symptoms in amyotrophic lateral sclerosis – assessment of treatment experience in a multicenter study

Respiratory function in 192 adult patients with spinal muscular atrophy (SMA) treated with nusinersen – a multicenter observational study

Phosphorylated neurofilament heavy chain (pNfH) concentration in cerebrospinal fluid predicts overall disease aggressiveness (D50) in amyotrophic lateral sclerosis

Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trial.

SOD1 gene screening in ALS - frequency of mutations, patients' attitudes to genetic information and transition to tofersen treatment in a multi-center program.

T1-weighted MRI texture analysis in amyotrophic lateral sclerosis patients stratified by the D50 progression model

Collaborators (2)

Christoph Neuwirth

André Maier

Make your next move.